Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Federal Circuit Invalidates Fosamax Patent
In Merck & Co. v. Teva Pharms. USA, Inc., 395 F.3d 1364 (Fed. Cir. 2005), the Federal Circuit reversed a lower court's ruling, and found that claims 23 and 37 of U.S. Patent 5,994,329 (the '329 patent) were invalid for obviousness. The '329 patent discloses a method of treating and preventing osteoporosis through less-than-daily administration of bisphosphonate compounds. This patent is listed in the Orange Book as covering Merck's Fosamax drug, which had sales of $3.2 billion in 2004.
In 2000, Teva amended an existing ANDA and sought FDA approval to market a generic version of Fosamax in 35 mg and 70 mg quantities. The '329 patent claims a method for treating and preventing osteoporosis by orally administering “about” 35 mg or 70 mg of alendronate monosodium trihydrate once-weekly. The district court found that Merck had acted as its own lexicographer and had redefined the ordinary meaning of “about” 35/70 mg to mean the equivalent of 35/70 mg.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
In Rockwell v. Despart, the New York Supreme Court, Third Department, recently revisited a recurring question: When may a landowner seek judicial removal of a covenant restricting use of her land?